U.S. Medical Equipment Stock News

Why Boot Barn Holdings stock is in focus after fresh earnings and guidance Boot Barn Holdings (BOOT) has drawn attention after reporting first quarter sales of US$593.52 million and net income of US$70.11 million, alongside new guidance that points to continued double digit sales growth and profitability. See our latest analysis for Boot Barn Holdings. Despite the strong first quarter update and larger credit facility announced on 29 July 2026, Boot Barn Holdings’ share price is down 8.13%...

Bank of America (BAC) is back in focus after reporting solid second quarter earnings supported by consumer spending, along with a 14% dividend increase that signals management confidence and draws fresh interest to the stock. See our latest analysis for Bank of America. At a share price of $61.95, Bank of America has seen a 30-day share price return of 6.15% and a 90-day share price return of 16.36%. The 1-year total shareholder return of 38.63% and 3-year total shareholder return of 113.36%...

Krystal Biotech walked into this earnings season with a premium biotech label and a stock that had climbed about 28% over the past three months. Today the air came out fast. The shares dropped about 8% to US$312.37 even as the company posted Q1 2026 revenue of US$116.4m and basic earnings per share of US$1.91. The headline for you is simple. Profits remain solid and margins look healthy for a commercial stage gene therapy company. The sell off reflects a reset in expectations, not a collapse...

Seagate Technology Holdings has delivered a very large 3 year gain while the valuation checks are more cautious, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the stock trades at a discount and the broader score pointing to limited support for a clear bargain. Over the last 3 years, Seagate shares have returned about 12x, which puts extra focus on whether the current price is still justified by future cash flows. Expectations tied to AI driven demand for high...

McDonald's Corporation recently declared a quarterly cash dividend of US$1.86 per share, payable on September 16, 2026 to shareholders of record as of September 1, 2026. This announcement comes as investors closely watch the company's upcoming earnings release for signals on how inflation and pressured consumer budgets are affecting its restaurant traffic and promotions. With earnings due shortly, we'll explore how concerns about value-seeking diners and discretionary spending may influence...

Cheniere Energy (LNG) recently affirmed a quarterly cash dividend of $0.555 per share, even as it reported a quarterly loss tied to $4.8 billion in LNG-linked derivative contract losses. See our latest analysis for Cheniere Energy. At a US$263.57 share price, Cheniere Energy has a 1 month share price return of 8.06% and a year to date share price return of 33.25%. The 5 year total shareholder return of 226.60% points to strong longer term compounding despite recent quarterly volatility. If...

Inflation is back in focus for Indian markets as higher energy and commodity prices feed into both wholesale and retail inflation. With WPI at 9.87% in June and CPI at 4.38%, rising input costs and government responses on food and fuel are reshaping expectations around margins and pricing power. For energy sector stocks, this mix of higher commodity prices and policy action can create both pressure and opportunity. This article looks at 3 stocks from the Energy Sector Stocks screener that are...

MSA Safety earnings and outlook move into focus MSA Safety (MSA) is back on investors’ radar after its second quarter update paired higher sales, stronger net income and earnings per share with a full year outlook that points to continued revenue growth. See our latest analysis for MSA Safety. MSA Safety shares have reacted strongly to the earnings beat and full year revenue outlook, with a 1 day share price return of 9.13% and a 90 day share price return of 14.77%. Over the past five years...

In late July 2026, reports claimed Tesla was exploring options to separate its China business ahead of a potential SpaceX merger, a story Elon Musk and Tesla representatives publicly rejected while emphasizing the ongoing importance of the Shanghai Gigafactory, which accounts for over half of global vehicle deliveries and about 18% of first-half 2026 sales. The controversy highlights how Tesla’s heavy manufacturing and supply-chain exposure to China intersects with its ambitions in AI,...

Mercantile Bank earnings and dividend move come into focus Mercantile Bank (MBWM) is back on investor radars after its second quarter earnings update and a higher declared quarterly dividend. This invites a closer look at how the stock aligns with different income and growth objectives. See our latest analysis for Mercantile Bank. Mercantile Bank’s recent earnings and dividend announcements come after a steady build in momentum, with the share price up 15.63% over 90 days and 26.19% year to...

Recent Performance Snapshot for Gen Digital Stock Gen Digital (GEN) has attracted attention after a period of mixed returns, with the stock up over the past month and past 3 months, while the 1 year total return shows a decline. For context, the company reports annual revenue of about US$5.0b and net income of US$973.0m, with both revenue and net income showing positive annual growth figures based on the latest data provided. See our latest analysis for Gen Digital. Recent trading suggests...

Why Safehold’s latest earnings matter for shareholders Safehold (SAFE) just released second quarter 2026 results alongside an update on its share buyback program, combining higher reported sales and net income with fresh capital moves that attracted investor attention. The company reported second quarter sales of US$31.74 million against US$16.71 million a year earlier, with revenue of US$114.65 million versus US$93.84 million and net income of US$30.16 million compared with US$27.95...

EPR Properties earnings update and what it means for the stock EPR Properties (EPR) has reported its second quarter 2026 results, showing higher sales and revenue but lower net income and earnings per share compared with the same period last year. The company also kept its full-year earnings guidance unchanged. See our latest analysis for EPR Properties. At a share price of US$62.07, EPR Properties has seen short term momentum cool, with a 1 day share price return that declined 3.03% and a 7...

Green Brick Partners, Inc. recently reported second-quarter 2026 results, with revenue of US$493.84 million and net income of US$74.17 million, and also announced that President and Chief Operating Officer Jed Dolson will become Co-Chief Executive Officer on October 15, 2026 as part of its long-term succession plan. The appointment of an internal leader who has overseen key operational roles, including the Texas region and Trophy Signature Homes, highlights the company’s emphasis on...

Why PROG Holdings Stock Is Back In Focus After Q2 Results PROG Holdings (PRG) is back on many watchlists after second quarter 2026 results topped expectations and full year guidance was lifted, prompting investors to reconsider how the stock is priced. See our latest analysis for PROG Holdings. Over the past year, PROG Holdings has attracted renewed interest, with the share price return of 49.88% year to date and 21.64% over 90 days pointing to building momentum, even as the 30 day share...

Community Trust Bancorp (CTBI) has drawn fresh attention after its board approved a higher regular quarterly dividend of $0.65 per share and a separate one time cash dividend of $0.06 per share. See our latest analysis for Community Trust Bancorp. The higher regular dividend and one time payout come as Community Trust Bancorp’s share price has gained momentum, with a 19.22% 90 day share price return and a 52.93% 1 year total shareholder return. If this kind of steady banking story has your...

Becton Dickinson (BDX) is back in focus after announcing a collaboration with EMS to launch a semaglutide therapy in Brazil, using BD’s Vystra injection pen platform for chronic disease treatment. See our latest analysis for Becton Dickinson. Becton Dickinson’s recent collaboration news comes on the heels of a 10.92% 90 day share price return, even as the year to date share price return is down 15.04%. The 1 year total shareholder return of 22.43% points to momentum rebuilding after weaker...

Fed Chair Kevin Warsh’s push for fewer rate meetings and less frequent guidance could make each policy decision a bigger market event, and that often brings sharper moves in volatility-related instruments. For investors who follow volatility-driven trading and investment products, this shift in Fed communication could reshape how certain stocks behave around macro headlines and data releases. This article looks at 3 stocks from our Volatility-Driven Trading and Investment Products screener...

On 29 July 2026, index provider S&P Dow Jones Indices added Five9, Inc. (NasdaqGM:FIVN) to the S&P 1000, S&P 600, S&P Composite 1500, and the S&P 600 Information Technology sector index, formally recognizing the company within several key US equity benchmarks. This broad index inclusion can increase Five9’s visibility and index-linked ownership, potentially amplifying how investors weigh its cloud contact center and AI-driven customer experience business model. We’ll now examine how Five9’s...

Tariffs are adding pressure on US consumers through higher prices and on US companies through rising input costs. For US domestic focused consumer staples stocks, that mix of inflation, tariff exposure and policy uncertainty can either support pricing power or squeeze margins, depending on how each business is set up. This article looks at how current tariff trends intersect with a curated screener of US consumer staples stocks that focus on the home market. You will see 3 stocks that appear...

Nektar Therapeutics recently initiated the first two global registrational Phase 3 trials, ZENITH AD‑1 and ZENITH AD‑2, evaluating rezpegaldesleukin in patients aged 12 and older with moderate‑to‑severe atopic dermatitis across North America, Europe and Asia‑Pacific. This marks a key step for rezpegaldesleukin, a first‑in‑class T‑reg focused biologic with FDA Fast Track status, aiming for differentiated immune‑modulating treatment options in atopic dermatitis and other autoimmune...

In July 2026, VEON Ltd. reported second-quarter 2026 results showing sales of US$1,271 million and net income of US$122 million, alongside higher first-half revenues but lower earnings compared with the prior year. On the same day, VEON also raised its full-year 2026 revenue growth guidance to a 15%–18% year-over-year range, signaling greater management confidence despite compressed earnings. Next, we will examine how VEON’s higher 2026 revenue growth guidance might influence its existing...

Antero Resources reported past second-quarter 2026 results with revenue of US$1,559.84 million, net income of US$278.66 million, record production volumes across gas and liquids, and reduced impairment charges compared with a year earlier. The company also raised its 2026 production guidance and continued share repurchases, signaling management confidence in its operating performance and capital allocation priorities. We’ll now examine how Antero’s stronger-than-expected earnings and higher...

Dyne Therapeutics has received U.S. FDA clearance to begin a Phase 1 trial of DYNE-302 in facioscapulohumeral muscular dystrophy, while also reporting a second-quarter net loss of US$178.56 million and basic loss per share of US$1.08, both higher than a year earlier. This clearance advances Dyne’s FORCE platform into a third clinical program targeting a rare muscle disease with no approved therapies, shortly after the company raised US$375.15 million in a follow-on equity offering. We’ll now...